Globe Life Financial Statements (GL)

Globe Lifesmart-lab.ru   FY2021 FY2022 FY2023 FY2024 FY2025   LTM ?
Report date 24.02.2022 23.02.2023 28.02.2024 26.02.2025 25.02.2026   07.05.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 5 121 5 227 5 448 5 778 5 999   6 078
Operating Income, bln rub 1 275 1 102 1 194 1 327 1 463   1 515
EBITDA, bln rub ? 1 358 1 193 1 297 1 454 1 592   1 609
Net profit, bln rub ? 1 031 894.4 970.8 1 071 1 161   1 177
OCF, bln rub ? 1 438 1 422 1 482 1 402 1 396   1 385
CAPEX, bln rub ? 38.2 27.9 49.6 71.0 142.5   155.6
FCF, bln rub ? 1 399 1 394 1 433 1 331 1 254   1 230
Dividend payout, bln rub 80.0 80.5 84.1 85.5 86.1   87.3
Ordinary share dividend yield, % 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 7.76% 9.01% 8.67% 7.98% 7.41%   7.41%
OPEX, bln rub 412.4 439.0 446.0 543.6 541.0   799.1
Cost of production, bln rub 3 434 3 686 3 807 3 908 3 995   3 764
R&D, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Interest expenses, bln rub 83.5 90.4 102.3 127.1 141.2   140.2
Assets, bln rub 29 768 25 987 28 051 29 076 30 814   30 966
Net Assets, bln rub ? 8 643 3 950 4 487 5 306 5 975   6 085
Debt, bln rub 2 026 2 077 2 116 2 740 2 625   2 779
Cash, bln rub 21 467 16 710 18 055 17 405 18 049   439.0
Net debt, bln rub -19 440 -14 633 -15 939 -14 666 -15 423   2 340
Ordinary share price, rub 93.7 111.5 139.9   139.2
Number of ordinary shares, mln 102.1 97.9 95.1 83.9 80.9   78.4
Market cap, bln rub 9 566 0 0 9 362 11 308   10 913
EV, bln rub ? -9 874 -14 633 -15 939 -5 304 -4 115   13 252
Book value, bln rub 3 246 -2 068 -2 004 -1 681 -1 515   5 594
EPS, rub ? 10.1 9.13 10.2 12.8 14.4   15.0
FCF/share, rub 13.7 14.2 15.1 15.9 15.5   15.7
BV/share, rub 31.8 -21.1 -21.1 -20.0 -18.7   71.3
EBITDA margin, % ? 26.5% 22.8% 23.8% 25.2% 26.5%   26.5%
Net margin, % ? 20.1% 17.1% 17.8% 18.5% 19.4%   19.4%
FCF yield, % ? 14.6% 14.2% 11.1%   11.3%
ROE, % ? 11.9% 22.6% 21.6% 20.2% 19.4%   19.3%
ROA, % ? 3.46% 3.44% 3.46% 3.68% 3.77%   3.80%
P/E ? 9.28 0.00 0.00 8.74 9.74   9.27
P/FCF 6.84 0.00 0.00 7.03 9.02   8.87
P/S ? 1.87 0.00 0.00 1.62 1.89   1.80
P/BV ? 2.95 0.00 0.00 -5.57 -7.46   1.95
EV/EBITDA ? -7.27 -12.3 -12.3 -3.65 -2.59   8.24
Debt/EBITDA -14.3 -12.3 -12.3 -10.1 -9.69   1.45
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
CAPEX/Revenue, % 0.75% 0.53% 0.91% 1.23% 2.38%   2.56%
Globe Life shareholders